Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
16.66
-1.24 (-6.93%)
At close: Dec 5, 2025, 4:00 PM EST
16.78
+0.12 (0.72%)
After-hours: Dec 5, 2025, 6:15 PM EST
Seres Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 5.39 | 0.14 | -113.72 | -250.16 | -65.58 | -89.13 | Upgrade
|
| Depreciation & Amortization | 13.46 | 14.67 | 15.14 | 6.63 | 5.95 | 6.58 | Upgrade
|
| Other Amortization | - | 1.41 | 1.14 | 0.71 | 2.53 | 0.55 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.02 | -146.39 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 3.27 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | -0.24 | 0.69 | 0.5 | 0.45 | Upgrade
|
| Stock-Based Compensation | 11.41 | 20.97 | 34.1 | 25.48 | 20.22 | 8.82 | Upgrade
|
| Other Operating Activities | -0.96 | 22.84 | 5.2 | 6.23 | 1.54 | 2.32 | Upgrade
|
| Change in Accounts Receivable | -0.78 | 6.61 | -8.67 | - | 9.39 | -7.6 | Upgrade
|
| Change in Inventory | - | -33.8 | -29.65 | - | - | - | Upgrade
|
| Change in Accounts Payable | -6.56 | -2.94 | -11.58 | 2.2 | 9.36 | -1.16 | Upgrade
|
| Change in Unearned Revenue | - | -4.12 | 6.41 | -7.13 | -4.36 | -11.57 | Upgrade
|
| Change in Other Net Operating Assets | -45.04 | -31.26 | -15.48 | -13.47 | 27.14 | -2.87 | Upgrade
|
| Operating Cash Flow | -23.06 | -148.61 | -117.35 | -228.82 | 6.69 | -93.61 | Upgrade
|
| Capital Expenditures | -0.31 | -0.38 | -7.98 | -9.82 | -9.57 | -0.59 | Upgrade
|
| Divestitures | - | 141.27 | - | - | - | - | Upgrade
|
| Investment in Securities | - | - | 18.56 | 92.25 | 73.65 | -158.3 | Upgrade
|
| Other Investing Activities | - | 1.4 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -0.31 | 142.29 | 10.58 | 82.43 | 64.09 | -158.89 | Upgrade
|
| Long-Term Debt Issued | - | - | 103.38 | 27.61 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -127.91 | -52.86 | -1.91 | -0.95 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | -127.91 | 50.52 | 25.7 | -0.95 | - | Upgrade
|
| Issuance of Common Stock | 2.98 | 37.53 | 21.19 | 103.9 | 2.13 | 303.42 | Upgrade
|
| Financing Cash Flow | 2.98 | -90.37 | 71.71 | 129.6 | 1.18 | 303.42 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0 | -0 | 0 | -0 | -0 | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | 0 | - | - | Upgrade
|
| Net Cash Flow | -20.39 | -96.69 | -35.07 | -16.79 | 71.95 | 50.92 | Upgrade
|
| Free Cash Flow | -23.37 | -148.99 | -125.33 | -238.64 | -2.88 | -94.2 | Upgrade
|
| Free Cash Flow Margin | -6657.55% | - | - | - | -1.99% | -283.61% | Upgrade
|
| Free Cash Flow Per Share | -2.69 | -19.18 | -19.58 | -44.16 | -0.63 | -23.61 | Upgrade
|
| Cash Interest Paid | - | 10.86 | 12.55 | 4.93 | 2.45 | 2.45 | Upgrade
|
| Levered Free Cash Flow | -81.85 | -60.11 | -103.56 | -87.82 | 14.04 | -52.03 | Upgrade
|
| Unlevered Free Cash Flow | -81.85 | -61.52 | -103.16 | -84.77 | 13.34 | -50.75 | Upgrade
|
| Change in Working Capital | -52.38 | -65.51 | -58.98 | -18.39 | 41.53 | -23.2 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.